Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Merck
Colorcon
Express Scripts
Boehringer Ingelheim

Last Updated: October 19, 2019

DrugPatentWatch Database Preview

US Patent Family Members and Approved Drugs for United States of America Patent: 2017333731

See Plans and Pricing

« Back to Dashboard

US Patent Family Members and Approved Drugs for United States of America Patent: US2017333731

These international patent data are derived from patent families, based on US drug-patent linkages. Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.
US Patent Number Estimated Patent Expiration Generic Name US Applicant US Tradename
  Start Trial 2029-04-17 rituximab Genentech RITUXAN
  Start Trial 2029-04-17 asparaginase Merck ELSPAR
  Start Trial 2029-04-17 interferon alfa-2b Schering INTRON A
  Start Trial 2029-04-17 epoetin alfa Amgen EPOGEN/PROCRIT
  Start Trial 2029-04-17 aldesleukin Chiron PROLEUKIN
  Start Trial 2029-04-17 filgrastim Amgen NEUPOGEN
>US Patent Number >Estimated Patent Expiration >Generic Name >US Applicant >US Tradename

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Colorcon
AstraZeneca
Boehringer Ingelheim
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.